Nirvana Life Sciences, Inc. engages in the research and development of therapeutic products derived from psychedelics. It also focuses on the development of methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The company was founded on May 11, 2011 and is headquartered in Vancouver, Canada.